Pharmaceutical Industry Dynamics: Production, consumption, and trade in OIC Member countries

Drug manufacturing plays a pivotal role in all-encompassing healthcare, particularly in Organization of Islamic Cooperation (OIC) appendage nations. This paper delves into the dynamics of drug results, consumption, and work within this diverse group of countries and their governments. Production: OIC nations exhibit a wide range of drug production volumes, varying from advanced production abilities to those reliant on imports. Factors doing result include supervisory foundations, technological progress, and expense climates. Consumption: The demand for pharmaceuticals within OIC appendage nations is affected by population headcount, affliction prevalence, healthcare foundation, and socio-business-related factors. Rising incomes and changeful behaviors contribute to increased use, especially for incessant afflictions and innovative analyses. Trade: Intra-OIC drug trade is important, compelled by diverse determinants such as geographic closeness, professional agreements, and financial unification initiatives. Export-familiarized nations influence competitive benefits in terms of result costs and quality principles, while significance-dependent countries, with their governments, inquire about access to essential cures and mechanics know-how. Challenges and Opportunities: Despite progress, drug manufacturing in OIC countries faces challenges containing supervisory harmonization, protected property created by original thought rights, and an approach to financing. However, events thrive, including the potential for OIC cooperation, technology transfer, and competency construction to enhance autonomy and meet healthcare needs. Conclusion: Understanding the action of pharmaceutical results, devouring, and supply with merchandise from OIC member nations is essential for policymakers, manufacturing stakeholders, and worldwide institutions to foster tenable incidents, improve approaches to cures, and promote community health in this place's diverse and active domain.

Authors

Institutions

Publication Details

Journal
Asian Journal of Research in Pharmaceutical Sciences
Published
2025-04-22
DOI
https://doi.org/10.52711/2231-5659.2025.00030
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmaceutical Industry Dynamics: Production, consumption, and trade in OIC Member countries

Asghar Mehdi, Zameer Ahmed, Geetha Kumari Das, Rehan Haider et al.
Asian Journal of Research in Pharmaceutical Sciences
Pharmaceutical Economics and Policy
article

Pharmaceutical Industry Dynamics: Production, consumption, and trade in OIC Member countries

Asghar Mehdi, Zameer Ahmed, Geetha Kumari Das, Rehan Haider, Sambreen Zameer
article en

Abstract

Drug manufacturing plays a pivotal role in all-encompassing healthcare, particularly in Organization of Islamic Cooperation (OIC) appendage nations. This paper delves into the dynamics of drug results, consumption, and work within this diverse group of countries and their governments. Production: OIC nations exhibit a wide range of drug production volumes, varying from advanced production abilities to those reliant on imports. Factors doing result include supervisory foundations, technological progress, and expense climates. Consumption: The demand for pharmaceuticals within OIC appendage nations is affected by population headcount, affliction prevalence, healthcare foundation, and socio-business-related factors. Rising incomes and changeful behaviors contribute to increased use, especially for incessant afflictions and innovative analyses. Trade: Intra-OIC drug trade is important, compelled by diverse determinants such as geographic closeness, professional agreements, and financial unification initiatives. Export-familiarized nations influence competitive benefits in terms of result costs and quality principles, while significance-dependent countries, with their governments, inquire about access to essential cures and mechanics know-how. Challenges and Opportunities: Despite progress, drug manufacturing in OIC countries faces challenges containing supervisory harmonization, protected property created by original thought rights, and an approach to financing. However, events thrive, including the potential for OIC cooperation, technology transfer, and competency construction to enhance autonomy and meet healthcare needs. Conclusion: Understanding the action of pharmaceutical results, devouring, and supply with merchandise from OIC member nations is essential for policymakers, manufacturing stakeholders, and worldwide institutions to foster tenable incidents, improve approaches to cures, and promote community health in this place's diverse and active domain.

Asian Journal of Research in Pharmaceutical Sciences
University of Karachi (PK), Dow University of Health Sciences (PK)
Openalex Percentile: Top 85%
Pharmaceutical Economics and Policy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.